CHINA NATIONAL MEDICINES CORPORATION LTD.

China National Medicines Corporation Ltd.

600511

CNE000001D56

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
35.46 ^CNY	+1.43%		+6.71%	+23.90%

Mar. 21	China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	MT
Mar. 21	Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	MT

China National Medicines Corporation Ltd.(XSSC:600511) dropped from S&P Global BMI Index

June 20, 2022 at 12:00 am EDT

Latest news about China National Medicines Corporation Ltd.

China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	Mar. 21	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	Mar. 21	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	Jan. 10	MT
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	Dec. 08	CI
China National Medicines' Profit Drops 16.1% in Q3	23-10-25	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Sinopharm CFO Retires; Successor Named	23-10-16	MT
China National Medicines Corporation Ltd.(XSSC:600511) added to S&P Global BMI Index	23-09-18	CI
China National Medicines Corporation Ltd.(XSSC:600511) added to FTSE All-World Index	23-09-18	CI
China National Medicines' Profit Climbs 14.2% in H1	23-08-24	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
China National Medicines' Q1 Profit Rises 10.9%	23-04-25	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23-03-23	MT
China National Medicines' 2022 Profit Up 12%	23-03-23	MT
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	23-01-13	MT
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	22-12-20	MT
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	22-11-30	MT
Sinopharm Unit Wins Nod to Launch Clinical Trial of COVID-19 Nasal Drug	22-11-29	MT
China National Medicines' Q3 Profit Rises 6%	22-10-23	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
China National Medicines Unit Isolates Monkeypox Virus, Begins Vaccine Development	22-10-21	MT
China National Medicines' H1 Net Profit Rises 13%	22-08-25	MT
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI

Chart China National Medicines Corporation Ltd.

Duration

Period

Chart China National Medicines Corporation Ltd.

More charts

China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.

Sector

Pharmaceuticals

Calendar

2024-04-24 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for China National Medicines Corporation Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

35.46 CNY

Average target price

42.3 CNY

Spread / Average Target

+19.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CHINA NATIONAL MEDICINES CORPORATION LTD.	+23.90%	3.7B
MCKESSON CORPORATION	+13.59%	69.11B
CARDINAL HEALTH, INC.	+5.67%	25.91B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+5.02%	8.01B
SINOPHARM GROUP CO. LTD.	-2.20%	7.91B
HUADONG MEDICINE CO., LTD	-27.52%	7.27B
H. LUNDBECK A/S	+0.18%	4.51B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+21.54%	4.48B
EBOS GROUP LIMITED	-2.45%	3.95B
GALENICA AG	-4.54%	3.79B

Pharmaceuticals Wholesale